During central nervous system development, oligodendrocyte progenitors elaborate multiple branched processes to contact axons and initiate myelination. Using cultured primary rat oligodendrocytes (OLGs), we have recently demonstrated that a cell surface protein belonging to the immunoglobulin superfamily, cell adhesion molecule-related, down-regulated by oncogenes (Cdon), is important in initiating OLG differentiation and axon myelination by promoting the formation of branched cellular processes; however, the molecular mechanism by which Cdon regulates OLG differentiation is not known. Here, using Cdon immunoprecipitation (IP) and liquid chromatography-tandem mass spectrometry analysis, we identified serine/threonine kinase TANK-binding kinase 1 (TBK1) as a candidate novel target of Cdon. We confirmed this interaction using co-IP and immunofluorescence with TBK1 antibodies, showing that TBK1 partly co-localizes with Cdon along cellular processes in puncta-like structures. We show that TBK1 is expressed throughout OLG differentiation, and surprisingly, that levels of phosphorylated TBK1 (ser172) increase during OLG maturation, while total levels of TBK1 protein decrease. To investigate function, TBK1 expression was knocked down using siRNA in OLG primary cultures, reducing protein levels by 69%. Two myelin-specific proteins, myelin basic protein and myelin-associated glycoprotein, were similarly reduced when examined at day 2 and day 4 of OLG differentiation. Reduced Cdon or TBK1 expression also decreased Akt phosphorylation at Threonine 308 in OLG. Our findings provide evidence that a Cdon-TBK1 complex is associated with Akt phosphorylation and early OLG differentiation.
Myelin is a specialized membranous structure that ensheaths large axons to increase the speed and efficiency of neural transmission. In the central nervous system (CNS), myelin is produced and maintained by oligodendrocytes (OLGs). A key step to achieve successful myelination/remyelination is proper differentiation of oligodendrocyte progenitors (OLPs), which has been proposed to be a limiting factor in the neuroinflammatory disease multiple sclerosis (Franklin 2002; Sim et al. 2002; Kuhlmann et al. 2008; Franklin and Goldman 2015) . Thus, identifying the molecular mechanisms that trigger OLG differentiation is of critical importance.
Our previous study has demonstrated that a cell surface protein, Cdon (cell adhesion molecule-related, down-regulated by oncogenes, also noted as Cdo), influences early OLG differentiation (Wang and Almazan 2016) . Cdon is an immunoglobulin superfamily glycoprotein that was initially shown to play important roles in myogenesis (Kang et al. 1998 (Kang et al. , 2003 and neurogenesis (Oh et al. 2009) . In OLG, we demonstrated that Cdon small interfering RNA (siRNA) knockdown decreased expression of myelin-associated glycoprotein (MAG) and myelin basic protein (MBP), two myelin-specific proteins, and reduced myelination of dorsal root ganglion neurons (DRGNs) in culture. In contrast, overexpression of full-length rat Cdon increased the branching complexity of OLG cellular processes and accelerated expression of myelin-specific markers. In co-culture experiments, OLG over-expressing Cdon displayed higher numbers of contact points with DRGN axons, which resulted in increased myelination. As the expression of Cdon was found to decrease with OLG maturation, we suggested Cdon is required particularly at the initiation of differentiation (Wang and Almazan 2016) .
In order to understand the mechanism by which Cdon regulates OLG differentiation, here we immunoprecipitated Cdon and subjected the protein complex to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by identification of potential interacting proteins by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Among the bands sent for LC-MS/MS, a novel interacting protein, TNF (Tumor Necrosis Factor) receptor associated factor (TRAF) family member-associated NF-kB activator binding kinase 1 (TANK-binding kinase 1, TBK1) or NF-jB-activated kinase, was identified in the Cdon co-IP lysates. TBK1 is an IjB kinase (IKK)-related and serine/ threonine kinase, which can be activated by phosphorylation on Serine-172 (Pomerantz and Baltimore 1999; Kishore et al. 2002) . TBK1 participates in multiple signaling pathways to regulate cellular events, such as innate immune responses, autophagy, and oncogenesis (Fitzgerald et al. 2003; Chien et al. 2006; Hacker and Karin 2006; Korherr et al. 2006; Saitoh et al. 2009; Wild et al. 2011) . Since functions have not been described for TBK1 in cellular differentiation or in the CNS, we studied its potential role in OLG development. We demonstrate that TBK1 is expressed at all stages of OLG differentiation, while the relative levels of the phosphorylated protein increase in mature cells or as myelination of DRGN axons proceeded in culture. siRNAmediated knockdown of TBK1 expression reveals that, similar to Cdon, TBK1 is required for OLG differentiation. Furthermore, we provide evidence that Akt, an important trophic signaling molecule, is a common downstream effector of Cdon and TBK1. These results provide evidence that Cdon interaction with TBK1 is associated with Akt activation and OLG differentiation.
Materials and methods

Reagents and supplies
Reagents were purchased from the following suppliers: Dulbecco's modified Eagle's medium (DMEM)/F12 medium, 7.5% bovine serum albumin (BSA) fraction V, Gibco fetal bovine serum (FBS), DMEM, Pierce TM Protein G Agarose, and penicillin/streptomycin from Thermo Fisher Scientific Inc (Burlington, ON, Canada); human recombinant platelet-derived growth factor-AA (PDGF AA ) and basic fibroblast growth factor from PeproTech (Rocky Hill, NJ, USA); nerve growth factor (2.5S) from Alomone Labs ( 
Primary oligodendrocyte cultures
Primary cultures of OLPs were prepared from the cerebral hemispheres of newborn Sprague-Dawley rats as described previously (McCarthy and de Vellis 1980; Almazan et al. 1993) . Lactating female rats with pups were ordered from Charles River Laboratories (St. Constance, QC, Canada). The experimental protocol was approved by the McGill Faculty of Medicine Animal Care Committee in accordance with Canadian Council on Animal Care guidelines. Briefly, the cerebral hemispheres of both male and female rat pups were dissociated and plated as mix-glia culture on poly-L-ornithine-coated flasks. Cultures were maintained at 37°C in 5% CO 2 . The media were changed after 4 days, and every other day thereafter. The initial culture was maintained for 11-12 days before OLP purification by mechanical shake-off as previously reported (Cohen and Almazan 1994) . OLPs were plated on PDL-coated culture dishes and grown in serum-free medium (SFM) consisting of DMEM/F12, 0.1% BSA, 25 lg/mL human transferrin, 30 nM triiodothyronine, 20 nM hydrocortisone, 20 nM progesterone, 10 nM biotin, 5 lg/ mL insulin, 16 lg/mL putrescine, 30 nM selenium, and the mitogenic growth factors basic fibroblast growth factor (5 ng/ mL) and PDGF AA (5 ng/mL). To differentiate OLPs, the mitogens were removed from the medium and the cultures supplied with 1% heat inactivated newborn calf serum. Culture medium was replaced every 2 days under all experimental conditions.
Rat DRGN cultures
Purified DRGNs cultures were prepared as described previously (Giasson and Mushynski 1996; Fragoso et al. 2003) . The experimental protocol was approved by the McGill Faculty of Medicine Animal Care Committee in accordance with Canadian Council on Animal Care guidelines. Time-pregnant female rats were purchased from Charles River Laboratories. Briefly, dorsal root ganglia (DRGs) were dissected from Sprague-Dawley rat embryos at 15-16 days of gestation (the sex of the embryos was not determined); cells were dissociated with trypsin and plated onto rat tail collagencoated dishes. The cultures were maintained with 25 ng/mL nerve growth factor in serum-free N1 media (consisting of DMEM/F12, 0.1% BSA, 5 lg/mL insulin, 30 lg/mL transferrin, 5 lg/mL selenium, 6.29 lg/mL progesterone, 16.1 lg/mL putrescine). The antimitotic, Ara-C (1 lM), was applied for two pulses of 24-h at the beginning of the culture in order to rid them of proliferating Schwann cells and fibroblasts. Myelination was initiated in the third week of culture by the addition of OLPs, plated at a density of 0.7 9 10 5 cells/cm 2 . At this stage, DRGNs are morphologically mature, displaying a profuse axonal network. The medium was replenished every 2 days.
Preparation of N-cadherin-Fc-coated coverslips/dishes Recombinant Protein A in phosphate-buffered saline (PBS) was used to coat the coverslips/dishes (8 lg/cm 2 ) for 1 h at 21-25°C. Following two washes with PBS, the coverslips/dishes were coated with recombinant N-cadherin-Fc or control IgG-Fc (100 ng/cm 2 ) for another hour at 37°C. Plates/coverslips were rewashed with PBS prior to OLPs plating.
Co-immunoprecipitation and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis
OLPs on day 1 of differentiation were lysed in IP buffer (20 mM HEPES, pH 7.5; 150 mM NaCl; 1.5 mM MgCl 2 ; 0.5% Triton-X 100; 5% glycerol) supplemented with protease and phosphatase inhibitors and placed on ice for 30 min. Samples were centrifuged and the supernatants collected for IP. A quantity of 500-750 lg of protein lysates (1-1.5 lg/lL) were incubated with 2 lg of Cdon or control goat IgG antibody and rocked gently overnight at 4°C. After 16-18 h, pre-washed protein G beads were added into protein lysate-antibody mixture for another 3 h. The immune complexes were collected by centrifugation at 100 g, followed by five washes with IP lysis buffer. A small volume of 29 sample buffer was added, boiled for 5 min, and proteins were resolved by SDS-PAGE and analyzed by western blotting or silver staining. For the western blots, TrueBlot conformation specific secondary antibodies were used. For LC-MS/MS analysis, targeted bands were collected and sent to the proteomics facility at the Institute for Research in Immunology and Cancer (IRIC), University of Montreal.
Western blotting
After treatment, cells were lysed in radioimmunoprecipitation assay buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1% SDS, 50 mM Tris pH 8.0). Protein concentration was determined using the bicinchoninic acid assay. Total protein was diluted with loading buffer (5X: 2% SDS, 5% glycerol, 5% b-mercaptoethanol, 0.01% bromophenol blue) and boiled for 5 min before loading on gels (10-25 lg/well). Electrophoretic separation of the samples was performed on SDS-PAGE and transferred to nitrocellulose membranes. Blots were blocked with 5% dry milk in Tris-buffered saline with 0.1% Tween-20 and incubated with appropriate primary and secondary antibodies. Immunoreactive signals were visualized by enhanced chemiluminescence and quantified by densitometry. To normalize for equal loading and protein transfer, the membranes were reprobed with an antibody against an internal control on each blot.
Transfection: siRNA transfections and over-expression transfection siRNAs designed to target Cdon, TBK1 and non-target control pools were purchased from GE Healthcare Dharmacon Inc. Control siRNA pool target sequences: 1. UGGUUUACAUGUCGACUAA; 2. UGGUUUACAUGUUGUGUGA; 3. UGGUUUACAUGUUU UCUGA; 4. UGGUUUACAUGUUUUCCUA. Cdon siRNA pool target sequences: 1. CGAUCAAUCUUCUAGGUAU; 2. AUGCA UUAAUUGUCGGAAU; 3. CCUGCGAAGUUCACGGGAA; 4. CAGAAGUGCAGUCGGCGAA. Tbk1 siRNA pool target sequences: 1. GGGAACAUCAUGCGCGUCA; 2. CUAGAGAG UUAGAGGACGA; 3. AUCAAGAACUAAUGCGAA; 4. UCACA GAGAUUUACUAUCA.
Primary OLGs were nucleofected with an Amaxa nucleofector before analysis using the Nucleofector TM Kit for Primary Mammalian Glial Cells (VPI-1006; Lonza, Mississauga, ON, Canada). Cells were trypsinized and centrifuged at 200 9 g at 4°C for 5 min. Supernatant was removed and cell pellets were resuspended in 150 lL of the nucleofection reagent premixed with 15 lL of 20 lM siRNA control pool, on-target TBK1, or on-target Cdon. OLPs were nucleofected using the A-017 program in the nucleofection device (Nucleofector I) and prewarmed DMEM with 6% FBS was immediately added to facilitate their survival and attachment to PDL-coated plates. One day after nucleofection, culture medium was changed to SFM with growth factor for 24 h more before differentiation in SFM with 1% newborn calf serum.
The full length rat Cdon, tagged with eGFP protein, cDNA expression construct was generously provided by Dr. Robert S. Krauss (Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, USA). The TBK1-flag expression cDNAwas purchased from GenScript (Piscataway, NJ, USA). Amaxa nucleofector was used for Cdon or TBK1 over-expression as described above, except the 150 lL nucleofection reagent was premixed with 2 lg of plasmid pCArCdon-eGFP or pcDNA3.1-flag-TBK1. After nucleofection, OLPs were allowed to recover with 6% FBS in DMEM for 24 h on PDLcoated plates. Culture medium was then changed to SFM with growth factor for another 24 h before differentiation. Overexpression was confirmed by immunostaining and western blotting for anti-Cdon or anti-GFP and anti-TBK1 antibodies.
Immunocytochemistry Immunofluorescence was performed as described (Cohen and Almazan 1994; Radhakrishna and Almazan 1994) . Briefly, cultures on PDL-coated plastic coverslips were exposed to anti-GalC or anti-MAG mouse mAbs at 37°C for 30 min, fixed with 4% paraformaldehyde in PBS, and incubated with Alexa 488-or 594-conjugated secondary antibodies. For Cdon, TBK1 and Olig2 immunostaining, cells were post-fixed with 100% methanol for 5 min at À20°C. After washing with PBS three times, coverslips were blocked with antibody dilution reagent (10% horse-serum with 0.1% Triton-x 100 in PBS) for 15 min followed by incubation with primary antibodies overnight at 4°C. Coverslips were washed three times with PBS, incubated with fluorescence-conjugated secondary antibodies for 1 h at 21-25°C and mounted in ImmunoMount.
Cells were imaged using a Zeiss LSM 710 confocal microscope (Carl Zeiss Canada Ltd., Toronto, ON, Canada) (McGill Life Sciences Imaging Facility) and Zeiss LSM acquisition software. Images were taken as Z-stacks, compiled as three-dimensional projections, and processed using Zen 2009 Image Browser software (Carl Zeiss, Jena, Germany). Numbers of cells expressing myelinspecific markers (GalC and MAG) were counted. The results are expressed as a percentage of the total Olig2-positive cells; since Olig2 is a transcription factor expressed by OLGs at all developmental stages.
Quantification and statistical analysis Densitometric quantifications of western blots were performed using AlphaEase quantification software (AlphaInnotech, San Leandro, CA, USA). Results were plotted and analyzed using GraphPad 5.0 software; GraphPad Software Inc., San Diego, CA, USA. Statistical significance was determined using unpaired t-tests when comparing two groups. Results are expressed as the means AE SEM. A value of p < 0.05 was considered statistically significant.
Results
Validation of Cdon binding partners: TBK1 is associated with Cdon in oligodendrocytes
In order to understand how Cdon regulates OLG differentiation, our first experimental strategy was to examine some known interacting proteins, which were reported to form a protein complex with Cdon in myoblasts or neurons (Takaesu et al. 2006; Bae et al. 2009a Bae et al. , 2010 Oh et al. 2009; Lu and Krauss 2010; Jeong et al. 2014) . One of the best characterized binding partners is N-cadherin. Through N-Cadherin ligation, Cdon can associate with two scaffoldtype proteins JLP and Bnip2 to recruit the protein kinase p38MAPK or the Rho GTPase Cdc42 to ultimately regulate myogenic differentiation (Kang et al. 2008; Lu and Krauss 2010) . In OLG development, N-Cadherin has been shown to be involved in OLG-axon contact and myelination (Schnadelbach et al. 2001) . Considering all pieces of evidence mentioned above, we proceeded to validate if Cdon interacts with N-Cadherin. Thus, using OLG primary culture lysates, the Cdon immunoprecipitate was analyzed for the presence of N-cadherin and other known potential interacting proteins, including cAbl, p38a, JLP, and Lrp6, using specific antibodies on western blots.
In co-immunoprecipitation (IP) experiments, protein lysates were collected from day 1 of OLG differentiation, when Cdon expression is the most abundant (Wang and Almazan 2016) , and incubated with Cdon antibody or goat IgG control. However, N-Cadherin was not detected in the Cdon-IP complex in OLG alone cultures (Fig. 1a) . In addition, except for the scaffold protein JLP, we did not find other potential signaling molecules, including p38a or cAbl, forming a complex with Cdon. As complex formation may require homophilic binding of N-Cadherin in-trans, as in myoblasts (Lu and Krauss 2010) , and considering that N-Cadherin is also expressed in neurons (Hatta et al. 1988) , we examined Cdon immunoprecipitates from DRGN/OLG co-cultures. However, as shown in Fig. 1(c) , N-Cadherin and p38a were not detected in our co-culture Cdon immunoprecipitates. To mimic N-Cadherin ligation, OLPs were plated on recombinant N-Cadherin-Fc-coated dishes, but p38 and cAbl were still not detected in the Cdon-IP protein complex (Fig. 1d) . Another experimental approach to determine potential interaction of Cdon and N-cadherin was to assess their localization in OLGs using coimmunostaining and fluorescent confocal microscopy with selective antibodies. Figure 1(e) , f show that N-Cadherin does not appear to be co-localized with Cdon. All these results suggest that Cdon regulates OLG differentiation, possibly not through binding with N-Cadherin or by regulating p38 signaling.
In addition to N-Cadherin-p38 signaling pathways, we also examined if Lrp6, a co-receptor for Wnt signaling, was present in the immunoprecipitates as Cdon can induce neuronal differentiation through interactions with Lrp6 to further suppress Wnt signaling (Jeong et al. 2014) . Wnt is a negative regulator of OLG differentiation during both development and remyelination (Fancy et al. 2009; Ye et al. 2009 ). However, Fig. 1(b) shows Lrp6 was not found in Cdon protein complexes.
In order to search for other OLG Cdon targets, proteins pulled-down in association with Cdon were then separated by SDS-PAGE and revealed by silver staining (Fig. 2a) . When compared with background proteins isolated in parallel with goat IgG IP, several bands appeared to be specifically present in the Cdon antibody IP lysates. The amino acid sequence of the targeted bands was then analyzed by LC-MS/MS. Among the sequenced samples, we identified the candidate interacting protein TBK1. The peptides obtained covered~14% of the total TBK1 protein sequence (Fig. 2b) . The interaction between TBK1 and Cdon was validated by western blot analysis of the IP with specific TBK1 antibodies (Fig. 2c) . These results provide evidence that TBK1 forms a complex with Cdon in OLGs.
Subcellular localization and developmental expression of TBK1 in oligodendrocytes
The subcellular localization of TBK1 is regulated by interactions with various intracellular adaptor proteins (Goncalves et al. 2011; Li et al. 2011; Helgason et al. 2013; Rudashevskaya et al. 2013) . We investigated the relative subcellular localizations of TBK1 and Cdon in OLG (Wang and Almazan 2016 ). Since Cdon is not an abundantly expressed protein, and the TBK1 antibody does not seem to have a strong affinity to the epitope, we over-expressed Cdon and TBK1 together in OLGs to visualize their distribution by immunofluorescent microscopy. After nucleofection in OLP, cells were fixed on day 1 of differentiation when Cdon protein is most abundant in OLG (Wang and Almazan 2016) . Immunocytochemical analysis revealed TBK1 mainly expressed in the cytoplasm (Fig. 3a) . A portion of TBK1 and Cdon immunoreactivity clearly overlapped along cellular processes. This distribution is consistent with our findings from co-IP, and provides evidence for a molecular complex that includes TBK1 and Cdon in OLGs. Notably, our immunocytochemical analysis reveals co-localization of Cdon and TBK1 in puncta-like structures along processes, similar to those we have previously described for Cdon in OLGs (Wang and Almazan 2016) .
Mouse transcriptome databases document expression of Tbk1 mRNA in OLPs and early differentiated OLGs (Zhang et al. 2014) . To examine levels of TBK1 protein during OLG development, OLPs were induced to differentiate by removal of mitogens, and harvested from day 0 to day 5 of differentiation. Western blot analysis demonstrated TBK1 expression in primary OLG matured in cell culture, from the progenitor stage to day 4-5 of differentiation, with relative levels decreasing as OLGs accumulated the mature myelin protein MAG (Fig. 3b) . TBK1 activation is associated with phosphorylation at Ser172 (Kishore et al. 2002) . Using a pTBK1-Ser 172 specific antibody on western blots, we showed that the relative levels of pTBK1 gradually increased as the cells differentiated (Fig. 3b) , even as total TBK1 decreased. Similar results were obtained in cultures of OLGs and DRGs. The pTBK1-Ser 172 signal was most abundant on day 3 of co-culture (Fig. 3c) , while total TBK1 remained constant. Our findings indicate that TBK1 is expressed in both OLPs and differentiated OLGs, and that phospho-TBK1 increases with OLG maturation, suggesting that the kinase activity of TBK1 may contribute to OLG maturation/ myelination.
siRNA-mediated TBK1 knockdown reduces myelin-specific protein expression during OLGs differentiation and reduces myelin markers in OLG membrane sheets To investigate its functional significance during OLG differentiation, TBK1 expression was reduced in OLPs by siRNA-mediated knockdown. Forty-eight hours following nucleofection with siRNAs directed against TBK1 (siTBK1) or control siRNA (siCtl), OLPs were then differentiated for 1-4 days before analysis. To assess TBK1 protein reduction, OLG lysates differentiated for 1 day (72 h after nucleofection) were analyzed by western blotting, revealing a~70% decrease in TBK1 (Fig. 4a) . Western blot analyses of lysates collected from different stages of differentiation demonstrated a significant reduction in levels of MAG and MBP at both day 2 and 4 of differentiation in the TBK1 siRNAtransfected samples as compared to control ( Fig. 4b and d) .
The expression of myelin-specific lipids (galactocerebroside, GalC) and proteins (MAG) on OLG membrane sheets and the transcription factor Olig2 was followed by immunocytochemistry in nucleofected cells. On day 2 of differentiation, the number of Olig2 positive cells co-staining with GalC decreased from 50.6 AE 0.76% in controls to 38.4 AE 0.8% in TBK1 siRNA-treated cells (Fig. 4c and e) . Similarly, the numbers of MAG+/Olig2 cells were decreased from 49 AE 0.83% to 33.2 AE 0.84% (Fig. 4c and e) . These results provide evidence that knockdown of TBK1 expression inhibits or delays OLG differentiation.
Cdon and TBK1 are upstream of Akt signaling TBK1 is a multifunctional kinase that acts as a key node in multiple signaling pathways including IKK, NFjB, and Akt to regulate innate immunity and oncogenic transformation (Chien et al. 2006; Ou et al. 2011 ). Since we found TBK1 can form a complex with Cdon, and have obtained evidence that both proteins influence OLG differentiation, we then investigated which signaling pathway is involved in regulating this cellular event. Previous studies indicate that Cdon can regulate p38, Akt, and ERK signaling (Takaesu et al. 2006; Bae et al. 2010; Lee et al. 2012) , therefore, we focused on Akt as a possible common target of both TBK1 and Cdon. Akt, also known as protein kinase B), is a serine/threonine kinase responsible for phosphorylating and regulating many substrates involved in signaling by trophic factors. During OLG development, Akt can enhance OLG and OLP cell survival and myelination in CNS through a mTOR pathway (Flores et al. 2008; Narayanan et al. 2009 ). To address the possibility that Akt may be a downstream effector of Cdon and TBK1, we examined Akt phosphorylation (T308 and S473) in OLG protein lysates after TBK1 or Cdon siRNA treatments. Fortyeight hours after nucleofection, the cells were harvested for analysis. In both TBK1 and Cdon siRNA-transfected cells, pAkt-T 308 was found to be decreased (p < 0.05) compared to a siRNA control. pAkt-S 473 exhibited a tendency to decrease in both TBK1-and Cdon siRNA-transfected cells, but the differences from controls did not reach statistical significance (Fig. 5a and b) . Examination of pERK in Cdon siRNAtransfected OLGs revealed no difference from controls. These results support the conclusion that TBK1 and Cdon function as upstream of Akt signaling.
Discussion
Immunoglobulin superfamily cell-cell interaction proteins, including contactins and neurofascin (Koch et al. 1997; Tait et al. 2000; Traka et al. 2002; Bozzali and Wrabetz 2004) , play multiple functions in CNS myelination. We have recently reported that another immunoglobulin superfamily member, Cdon, is a positive regulator of OLG growth and myelination with a functional role in early differentiation (Wang and Almazan 2016) . Since this plasma membrane Fig. 3 Spatial localization of TBK1 in oligodendrocytes (OLGs) and developmental expression of TBK1 in OLGs cultured alone and in coculture with dorsal root ganglion neurons (a) Upper panel: oligodendrocyte progenitor were co-transfected with rCdon-eGFP and TBK1-flag constructs and co-immunostained with antibodies for GFP (green) and TBK1 (red) on day 1 of differentiation. TBK1 was detected in the cytoplasm and along cellular processes of day 1 differentiated immature OLGs. Lower panel: The images correspond to the inset of the white square in higher magnification showing varicosity-like structures, revealing partial overlap between the TBK1 signal and cell adhesion molecule-related, down-regulated by oncogenes (Cdon). (b) Protein samples from OLGs cultured alone from day 0 to day 5 of differentiation were collected. A/M, astrocyte and microglia cell lysates demonstrate cell-type specific expression of Cdon. (c) Protein lysates from day 0 to day 3 dorsal root ganglion neuron (DRGN)-OLG coculture. TBK1 expression is maintained in different differentiation stages. The phosphorylated form of TBK1 accumulates in more mature OLGs when myelin-associated glycoprotein becomes more abundant in both OLG alone and DRGN-OLG co-culture. a-tubulin was used as a loading control in western blots. GFP, green fluorescent protein.
protein is known to form multiprotein complexes to regulate intracellular signaling pathways, the objective of the current work was to further elucidate the mechanisms by which it regulates OLG development by investigating proteins interacting with Cdon. Here, we identified TBK1, the serine/ threonine kinase TANK-binding kinase 1, from a screen of proteins that co-IP with Cdon in OLG lysates. We show that TBK1 partially co-localizes with Cdon in OLG cellular processes in varicosity-like structures. Furthermore, we found TBK1 to be expressed throughout OLG differentiation; and show that siRNA-mediated knockdown of TBK1 expression reduces the capacity of OLPs to differentiate. The values represent mean AE SEM of triplicate samples. Statistical differences were computed using independent t-tests (*p < 0.05, **p < 0.01, ***p < 0.005). 
Validation of Cdon binding partners
In our first experimental approach, we assessed the potential protein targets that could interact with Cdon in OLG primary cultures using co-IP. Among the potential molecules that we had tested, only the scaffold protein JLP was found in Cdon immunoprecipitates. The results presented including the costaining in OLG suggest that Cdon does not interact with Ncadherin to regulate OLG differentiation; however, as the interaction of Cdon and N-cadherin may by dynamic or transient, we do not exclude the possibility of an interaction based on our analysis. Other proteins/signaling molecules related to Cdon function in myoblasts are: (i) neogenin, a DCC-like (Deleted in Colorectal Cancer-like) molecule, that through netrin stimulation can promote myogenic differentiation (Kang et al. 2004; Bae et al. 2009b) ; and (ii) the adaptor protein, adaptor protein containing pleckstrin homology domain/phosphotyrosine-binding domain/leucine zipper motif 1 (APPL1) which activates Akt signaling (Bae et al. 2010) ; (iii) in addition, during craniofacial development and vertebrate embryogenesis, together with BOC or Gas1 or both, Cdon acts as a co-receptor that directly binds sonic hedgehog (Shh) to regulate downstream Shh signaling pathways (Okada et al. 2006; Tenzen et al. 2006; Allen et al. 2007; Bae et al. 2011; Bergeron et al. 2011) . Given that these signaling pathways all have particular roles in OLG development, more work is required to determine if Cdon regulates OLG differentiation by one or more of these mechanisms.
TBK1 as a new target of Cdon
After assessing the potential contribution of candidate molecular mechanisms, we then investigated other possible targets by analyzing proteins isolated based on co-IP with Cdon. Although several novel bands were detected in the Cdon-IP when compared to control IgG IP, only the four best resolved and most abundant bands were collected and sent for protein identification. This analysis revealed a new Cdon interacting protein, TBK1. In OLGs, TBK1 localized to the cytoplasm and was detected partly co-localized with Cdon in varicosity-like structures, consistent with our previous study of Cdon. In our co-staining results, the morphology of the cells on day 1 after growth factor withdrawal is more differentiated than in normal untrasfected cell, and we recently showed that over-expression of Cdon increases the branching complexity of differentiating OLG (Wang and Almazan 2016) . It would be of interest to further investigate the cellular compartment that the Cdon-TBK1 complex is located in, and if its function is related to OLG process formation/branching and associated with other proteins regulating this process.
TBK1 function
The best studied function of TBK1 is in antiviral immune responses where it regulates NF-jB signaling pathways and activates IFN regulatory factor 3 (Pomerantz and Baltimore 1999; Fitzgerald et al. 2003; Hacker and Karin 2006) . TBK1 is also implicated in autophagy (Saitoh et al. 2009; Wild et al. 2011) and oncogenesis (Chien et al. 2006; Korherr et al. 2006) . In addition, recent reports have shown that mutations in TBK1 are associated with familial amyotrophic lateral sclerosis and frontotemporal dementia (Cirulli et al. 2015; Freischmidt et al. 2015 ). In the current study, by knocking down TBK1 protein expression with siRNA in primary OLG culture, we found that, similar to Cdon, TBK1 plays a positive role in regulating OLG differentiation. This conclusion is based on the observation that TBK1 knockdown reduces expression of myelin-specific markers in differentiating OLGs. In addition, TBK1 phosphorylation increases with OLG maturation and in myelinating DRGN-OLG co-cultures suggesting a distinct role of TBK1 in regulating this cellular event.
Cdon-TBK1 complex formation and relationship with Akt signaling TBK1 activity and function is largely controlled by intracellular adaptor proteins (Helgason et al. 2013) . These adaptors determine the location of TBK1 and also the signaling complexes for different cellular responses. Our study suggests TBK1 can form a complex with Cdon; however, the molecular domains involved and whether these two molecules interact with each other directly or through an adaptor protein remains to be explored. Cdon binds to APPL1 to regulate Akt signaling in myoblast differentiation (Bae et al. 2010) . APPL1 can regulate the activity of Akt by direct interaction with Akt and its upstream proteins (Yang et al. 2003; Lin et al. 2006; Mao et al. 2006; Varsano et al. 2006) . Other studies have reported that TBK1 can activate Akt through direct phosphorylation (Ou et al. 2011; Xie et al. 2011 ) and TBK1 can be recruited by APPL1 to regulate IFN regulatory factor 3-dependent gene expression in macrophages in response to viral and bacterial infections (Chau et al. 2015) . Based on these reports, we anticipated that: (a) APPL1 could be the adaptor protein for Cdon and TBK1 and that (b) Akt is the downstream effector of the Cdon and TBK1 complex. Notably, our findings in OLG cultures showed that siRNA knockdown of Cdon and TBK1 significantly decreased the level of pAkt-T 308 , which is in good agreement with our hypothesis that Akt can be regulated by Cdon and TBK1. However, whether TBK1 and Cdon can directly regulate Akt activity, as shown in macrophages by in vitro kinase assays remains to be determined (Joung et al. 2011) . Similarly, the requirement of APPL1 as a linkage between TBK1 and Cdon for the activation of Akt needs to be demonstrated. We also identified JLP in Cdon co-IP lysates, providing another possibility that JLP could be the adaptor protein for Cdon and TBK1. Additional studies will be required to determine the binding domain and the interaction between these factors.
Potential role of TBK1 kinase activity in OLG development In this study, the phosphorylation of TBK1 increases with OLG maturation, contrary to the reduced expression of Cdon detected with differentiation (Wang and Almazan 2016) . These observations suggest that, in the initial stages of differentiation, the kinase activity of TBK1 may not be required (or not as essential) when it is in a complex with Cdon. It has been reported that TBK1 activity requires Ser172 phosphorylation by auto-phosphorylation, which is essential for triggering TBK1-dependent signaling (Ma et al. 2012; Shu et al. 2013) . Thus, we postulate TBK1 may play different roles at different time points during OLG maturation. We speculate that at the initiation of differentiation Cdon recruits TBK1 to the cellular processes, regulating the formation or maintenance of cellular processes in early OLG differentiation through Akt signaling. As the cells begin to express mature myelin proteins like MAG and MBP, Cdon expression will drop; the distribution and accumulation of TBK1 protein will change, resulting in TBK1 activation by auto-phosphorylation with the ability to further regulate other downstream targets and myelination.
Other studies have shown that TBK1 participates in the regulation of lipid synthesis (Schmitt et al. 2011 ) and glycolysis in dendritic cells to further regulate lipogenesis through Akt activation (Everts et al. 2014) . As high levels of lipid synthesis are required for the formation of myelin, we postulate that another potential role of TBK1 kinase activity is the regulation of lipid synthesis in OLG maturation and myelination. While inhibitors targeting TBK1 kinase activity, such as compound BX795 and Amlexanox are available (Clark et al. 2009; Reilly et al. 2013) , they have significant off target effects and also inhibit kinases, such as PDK1 (an upstream regulator of Akt), p38 MAPK or IKK-e (Feldman et al. 2005; Reilly et al. 2013) . Thus, further development of more efficient and selective TBK1 inhibitors is required to investigate function in OLG development.
In summary, our findings indicate that TBK1 is a novel target of Cdon. We demonstrate a new functional role for TBK1 regulating OLG differentiation. Our results provide a critical foundation for further studies that will investigate whether TBK1 and Cdon cooperation directly regulates Akt signaling to better understand the molecular mechanism underlying OLG differentiation and myelination.
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